文献速递小儿眼科与斜弱视

基于临床数据注册中心的多变量分析:弱视治疗结局

Multivariable Analyses of Amblyopia Treatment Outcomes from a Clinical Data Registry.
PubMed 文献 · Ophthalmology · 2022-09-11

该回顾性数据库研究纳入2013–2019年注册的3–12岁新患者,采用美国眼科学会IRIS-50指标评估弱视治疗成功情况。多变量分析显示黑人儿童和Medicaid保险者治疗成功几率显著更低。

要点

  • 3–7岁组黑人儿童成功OR为0.71(95%CI 0.62-0.83),低于白人儿童。
  • Medicaid保险与两个年龄组成功几率降低独立相关(OR分别为0.65和0.84)。

核心结论

  • 以IRIS-50衡量的弱视治疗结局在3–12岁黑人儿童和Medicaid保险儿童中显著更差,作者强调需开发和测试改善这些儿童治疗结局的策略。

研究设计与样本

  • 回顾性数据库研究,纳入2013至2019年注册的3至12岁新患者,治疗由眼科医生按临床诊疗常规开具。

主要发现

  • 3–7岁组黑人儿童成功OR为0.71(95%CI 0.62-0.83),低于白人儿童。
  • 3–7岁组Medicaid保险与成功几率降低独立相关(OR 0.65;95%CI 0.60-0.71)。
  • 8–12岁组黑人儿童成功OR为0.81(95%CI 0.68-0.96),低于白人儿童;西班牙裔儿童成功几率升高(OR 1.16;95%CI 1.03-1.31)。
  • 8–12岁组Medicaid保险与成功几率降低相关(OR 0.84;95%CI 0.77-0.93)。

关键数值与推荐

  • IRIS-50由美国眼科学会开发,用于IRIS注册中心数据,指标涵盖与斜视、屈光不正或两者相关的单眼弱视。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To present multivariable analyses of factors associated with amblyopia treatment success using outcomes from a clinical registry. DESIGN: Retrospective database study. PARTICIPANTS: New patients 3 to 12 years of age being enrolled in the registry from 2013 to 2019. MAIN OUTCOME MEASURE: The IRIS-50 is an outcome measure for amblyopia treatment developed by the American Academy of Ophthalmology for use with data in the Intelligent Research in Sight (IRIS®) Registry. The measure specifications include unilateral amblyopia associated with strabismus, refractive error, or both. METHODS: Clinical care prescribed by the ophthalmologist. RESULTS: Eighteen thousand eight hundred forty-one children 3 to 7 years of age were eligible for IRIS-50, with 77.3% successful. Nine thousand seven hundred sixty-two children 8 to 12 years of age were eligible, with 55.5% successful. For the younger age group, multivariable analyses found that odds ratios (ORs) for success were significantly lower for Black children (0.71; 95% confidence interval [CI], 0.62-0.83) compared with White children. Medicaid insurance was associated independently with significantly lower success (OR, 0.65; 95% CI, 0.60-0.71). Among older children, Black children were less likely to be treated successfully (OR, 0.81; 95% CI, 0.68-0.96) compared with White children, whereas Hispanic children showed an increased chance of success (OR, 1.16; 95% CI, 1.03-1.31). Medicaid insurance for the older children also was associated with a decreased chance of success (OR, 0.84; 95% CI, 0.77-0.93). CONCLUSIONS: Amblyopia treatment outcomes measured by IRIS-50 were significantly poorer for Black children and those with Medicaid insurance 3 to 12 years of age. Disparate health outcomes demonstrated for these two factors emphasize the need to develop and test strategies to improve treatment outcomes for these children.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Repka MX, Li C, Lum F, et al. Multivariable Analyses of Amblyopia Treatment Outcomes from a Clinical Data Registry. Ophthalmology. 2022. PMID: 36100075. doi:10.1016/j.ophtha.2022.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。